Advisor Group Holdings, Inc. Vallon Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.42 - $2.27 $992 - $5,366	-2,364 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$1.79 - $8.0 $8,101 - $36,208	-4,526 Reduced 65.69%	2,364 $4,000
Q3 2021 Nov 05, 2021	BUY	$3.85 - $9.68 $9,671 - $24,316	2,512 Added 57.38%	6,890 $50,000
Q2 2021 Aug 02, 2021	BUY	$3.66 - $5.83 $8,238 - $13,123	2,251 Added 105.83%	4,378 $24,000
Q1 2021 May 13, 2021	BUY	$4.32 - $7.83 $9,188 - $16,654	2,127 New	2,127 $10,000

Ticker VLON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,512,800
Description
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.